www.fdanews.com/articles/179900-higher-heart-failure-rates-found-in-mom-implant-recipients
![](https://www.fdanews.com/ext/resources/test/Device_Images6/HipPain.gif?t=1480982975&width=430)
Higher Heart Failure Rates Found in MoM Implant Recipients
January 4, 2017
A recent Australian study suggests a higher incidence of first hospitalization due to heart failure among a group of male patients with ASR XL metal-on-metal (MoM) hip implants when compared to a similar group who received metal-on-polyethylene (MoP) implants.
However, the authors said more work is needed to establish whether having an ASR XL implant actually causes a higher incidence of heart failure.
According to Australia’s TGA, mounting evidence suggests that because the two moving parts of a MoM hip implant wear against each other, they can release trace amounts of cobalt and chromium, especially during the first 18 months after the operation. — Jeff Kinney